Mechanistically, glutamine was found to stabilize GLS1, thereby promoting its interaction with RNA polymerase subunit H (POLR2H) and RNA polymerase subunit E (POLR2E), which reduced the activity of RNA pol II, affecting hepatic steatosis in AFLD. The gene discussed is GLS; the disease is Hepatic steatosis.